POSITIVE Stroke Clinical Trial


Phase N/A Results N/A

Summary of Purpose

Primary Endpoint: The primary objective is to show that AIS patients, ineligible for or refractory to treatment with IV-tPA, with appropriate image selection, treated with mechanical thrombectomy within 6-12 hours of symptom onset have less stroke related disability and improved good functional outcomes as compared to those treated with best MT with respect to endpoint defined as: • 90-day global...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 February 2018.

1 Sep 2013 23 Apr 2013 1 Mar 2018 1 Mar 2018 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Factorial Assignment